$ACET
Adicet Bio, Inc. Common Stock
XNAS
$8.10
▼-16.49%-$1.60
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ACET down today? It is at $8.10 (-16.49%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACET spikes, and full due diligence on ACET — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACET 11 times in the last 30 days. Create a free account to track $ACET, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ACET is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on ACET today, peaking at 44.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystPrula-cel Bar for success to generate transformative market opportunity in patients with SLE with or without lupus nephritis Autoimmune Indications, from the latest SEC filing. Read it →The company is cleared to issue new shares on demand, but has not yet. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ra Capital Management, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -250K 2.7% of company | sold 21% | 933K | n/a | Apr 27, 26 |
Orbimed Advisors Llc Beneficial Owner (10%) | Sold (automatic/other) | -73K 0.8% of company | sold 7.3% | 923K | $459K at $6.29 | Apr 8, 26 |
Orbimed Advisors Llc Beneficial Owner (10%) | Sold (automatic/other) | -32K 0.3% of company | sold 49% | 33K | $202K at $6.38 | Apr 7, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +75K 0.8% of company | added 6.7% | 1.18M | $543K at $7.27 | Feb 20, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +74K 0.8% of company | added 7.2% | 1.11M | $535K at $7.21 | Feb 19, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +75K 0.8% of company | added 7.8% | 1.03M | $525K at $7.04 | Feb 18, 26 |
Harvey Brian Nicholas Officer | Sold (automatic/other) | -546 | sold 9.6% | 5K | $5K at $8.44 | Jan 24, 26 |
Schor Chen Officer | Sold (automatic/other) | -2K 0.02% of company | sold 20% | 7K | $15K at $8.44 | Jan 24, 26 |
Healey Don Officer | Sold (automatic/other) | -535 | sold 13% | 3K | $5K at $8.44 | Jan 24, 26 |
Aftab Blake Officer | Sold (automatic/other) | -535 | sold 15% | 3K | $5K at $8.44 | Jan 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
ACET is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on ACET today, peaking at 44.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ACET last traded at $8.10, down 16.49% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Adicet Bio, Inc. Common Stock (ACET) is next expected to report earnings on Wednesday, November 4, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACET Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACET 11 times in the last 30 days.
ACET (Adicet Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $91M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACET for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACET discussion
Sign in to ask a question or join the discussion.